Chronic beta-adrenergic activation-induced left ventricular systolic dysfunction is associated with systemic release of TNF-alpha and IL-1-beta in rats.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Pharmacological Reports

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 19904010
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The past, the present and the future of experimental research on myocardial ischemia and protection

  2009cited by this paper
• Molecular determinants of heart failure with normal left ventricular ejection fraction

  2009cited by this paper
• Cardiac dilatation and pump dysfunction without intrinsic myocardial systolic failure following chronic beta-adrenoreceptor activation.

  2007cited by this paper
• Cardiac hypertrophy induced by sustained β-adrenoreceptor activation: pathophysiological aspects

  2007cited by this paper
• Activation of AP-1 Contributes to the β-Adrenoceptor-Mediated Myocardial Induction of Interleukin-6

  2007cited by this paper
• Aldosterone Receptor Blockade Prevents the Transition to Cardiac Pump Dysfunction Induced by &bgr;-Adrenoreceptor Activation

  2005cited by this paper
• Review of trials in chronic heart failure showing broad-spectrum anti-inflammatory approaches.

  2005cited by this paper
• Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardio

  2005cited by this paper
• Involvement of the Serotonin 5-HT2B Receptor in Cardiac Hypertrophy Linked to Sympathetic Stimulation: Control of Interleukin-6, Interleukin-1&bgr;, and Tumor Necrosis Factor-&agr; Cytokine Production by Ventricular Fibroblasts

  2004cited by this paper
• Potassium Canrenoate, an Aldosterone Receptor Antagonist, Reduces Isoprenaline-Induced Cardiac Fibrosis in the Rat

  2004cited by this paper
• Transplantation of skeletal myoblasts secreting an IL-1 inhibitor modulates adverse remodeling in infarcted murine myocardium

  2004cited by this paper
• Regression of Isoproterenol‐Induced Cardiac Hypertrophy by Na+/H+ Exchanger Inhibition

  2003cited by this paper
• &bgr;-Adrenergic Activation Initiates Chamber Dilatation in Concentric Hypertrophy

  2003cited by this paper
• Inflammatory mediators and the failing heart: past, present, and the foreseeable future.

  2002cited by this paper
• Spironolactone and captopril attenuates isoproterenol-induced cardiac remodelling in rats.

  2001cited by this paper
• Reduction in Myocardial Collagen Cross-Linking Parallels Left Ventricular Dilatation in Rat Models of Systolic Chamber Dysfunction

  2001cited by this paper
• beta-adrenergic blockade in developing heart failure: effects on myocardial inflammatory cytokines, nitric oxide, and remodeling.

  2000cited by this paper
• Incidence and Epidemiology of Heart Failure

  2000cited by this paper
• Chronic beta-adrenergic stimulation induces myocardial proinflammatory cytokine expression.

  2000cited by this paper
• Myocardial tumor necrosis factor-α secretion in hypertensive and heart failure-prone rats.

  1999cited by this paper
• Tumor necrosis factor-alpha and interleukin-1beta synergistically depress human myocardial function.

  1999cited by this paper
• IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses.

  1998cited by this paper
• Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats.

  1998cited by this paper
• Rat models of hypertension, cardiac hypertrophy and failure.

  1998cited by this paper
• Animal models of human cardiovascular disease, heart failure and hypertrophy.

  1998cited by this paper
• Development of heart failure following isoproterenol administration in the rat: role of the renin-angiotensin system.

  1998cited by this paper
• Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension.

  1996cited by this paper
• Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD).

  1996cited by this paper
• Interleukin-1 beta modulates the growth and phenotype of neonatal rat cardiac myocytes.

  1995cited by this paper
• The role of nitric oxide in cardiac depression induced by interleukin-1 beta and tumour necrosis factor-alpha.

  1995cited by this paper
• Serial echocardiographic assessment of left ventricular geometry and function after large myocardial infarction in the rat.

  1994cited by this paper
• Progressive ventricular remodeling in response to diffuse isoproterenol-induced myocardial necrosis in rats.

  1994cited by this paper
• beta Adrenergic receptor desensitisation may serve a cardioprotective role.

  1992cited by this paper
• The fibrillar nature and structure of isoproterenol-induced myocardial fibrosis in the rat.

  1989cited by this paper

• Cardioprotective Effects of the GRK2 Inhibitor Paroxetine on Isoproterenol-Induced Cardiac Remodeling by Modulating NF-κB Mediated Prohypertrophic and Profibrotic Gene Expression

  2023cites this paper
• Pathological involvement of apoptotic and inflammatory molecules in cardiovascular remodeling in rats on high fructose diet-induced metabolic syndrome.

  2022cites this paper
• Qi-Li-Qiang-Xin Alleviates Isoproterenol-Induced Myocardial Injury by Inhibiting Excessive Autophagy via Activating AKT/mTOR Pathway

  2019cites this paper
• Effect of Kaempferol Pretreatment on Myocardial Injury in Rats

  2018cites this paper
• Purification characterization and inhibition studies on Phospholipase C from Opisthacanthus capensis (Black Scorpion) venom

  2018influential citation
• PEG-coated gold nanoparticles attenuate β-adrenergic receptor-mediated cardiac hypertrophy

  2017cites this paper
• Role of Cytokines in Heart Failure

  2017cites this paper
• Effect of aliskiren and carvedilol on expression of Ca2+/calmodulin-dependent protein kinase II δ-subunit isoforms in cardiac hypertrophy rat model

  2016cites this paper
• CARDIOPROTECTIVE EFFECT OF PERSEA AMERICANA MILL FRUIT EXTRACT IN EXPERIMENTAL MYOCARDIAL INFARCTION

  2015influential citation
• An investigation into the relationships between telomere length and cardiac function and geometry

  2014influential citation
• β-Adrenoreceptor Agonist Isoproterenol Alters Oxidative Status, Inflammatory Signaling, Injury Markers and Apoptotic Cell Death in Myocardium of Rats

  2014cites this paper
• Hemodynamic treatment aimed to reduce catecholamine toxicity in patients suffering from septic shock: an observational single center study.

  2013cites this paper
• Telomere length and adrenergic-induced left ventricular dilatation and systolic chamber dysfunction in rats

  2013cites this paper
• Genistein prevents isoproterenol-induced cardiac hypertrophy in rats.

  2012cites this paper
• An "I" on cardiac hypertrophic remodelling: imidazoline receptors and heart disease.

  2012cites this paper
• L’amélioration de la performance et de la structure cardiaque par la moxonidine chez les SHR est accompagnée d’une diminution des cytokines, de la MAPK p38 et de l’Akt

  2011influential citation
• Moxonidine improves cardiac structure and performance in SHR through inhibition of cytokines, p38 MAPK and Akt

  2011cites this paper
• Effect of U50,488H, a κ-opioid receptor agonist on myocardial α-and β-myosin heavy chain expression and oxidative stress associated with isoproterenol-induced cardiac hypertrophy in rat

  2010cites this paper
• Peripheral benzodiazepine receptor ligand Ro5-4864 inhibits isoprenaline-induced cardiac hypertrophy in rats.

  2010cites this paper